Recent evidence suggests that translocations act in concert with other genetic lesions to induce overt leukemia including deletion of genes such as cyclin-dependent kinase inhibitor 2A gene (CDKN2A) [4] or the more recently described deletion of IKZF1 (Ikaros) [5]. The gene discussed is CDKN2A; the disease is leukemia.